Wave Life Sciences Ltd. Accounts Payables 2011-2026 | WVE

Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.

Main types of accounts payable

Type of liability	Example
To suppliers and contractors	Goods received but not yet paid for
Taxes and fees	VAT, income tax, etc., not paid on time
Salaries	Employee wages not paid
To budgets	Insurance contributions to funds not paid
To founders	Founders provided borrowed funds
To banks	Overdue loan payments
Other	Fines, penalties, forfeits, customer prepayments, etc.

Impact on the company's financial performance

Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios
Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence
Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals)
Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated

Annual Accounts Payables Wave Life Sciences Ltd.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
16.3 M	12.8 M	16.9 M	7.28 M	13.8 M	9.07 M	13.1 M	7.6 M	4.94 M	2.81 M	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
16.9 M	2.81 M	10.5 M

Quarterly Accounts Payables Wave Life Sciences Ltd.

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
14.5 M	14.7 M	14.4 M	16.3 M	12.8 M	18.1 M	-	12.8 M	12.6 M	12.4 M	11.9 M	16.9 M	15.9 M	11.2 M	9.85 M	7.28 M	7.44 M	8.66 M	13.4 M	13.8 M	13.8 M	13.8 M	13.8 M	9.07 M	9.07 M	9.07 M	9.07 M	13.1 M	13.1 M	13.1 M	13.1 M	7.6 M	7.6 M	7.6 M	7.6 M	4.94 M	4.94 M	4.94 M	4.94 M	2.81 M	2.81 M	2.81 M	2.81 M	125 K	125 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
18.1 M	125 K	9.92 M

Accounts Payables of other stocks in the Biotechnology industry

Issuer	Accounts Payables	Price	% 24h	Market Cap	Country
Harmony Biosciences Holdings HRMY	17.7 M	$ 27.99	4.17 %	$ 1.59 B	USA
ARCA biopharma ABIO	3.46 M	-	1052.0 %	$ 415 M	USA
Acasti Pharma ACST	601 K	-	4.01 %	$ 150 M	Canada
Aptorum Group Limited APM	3.24 M	$ 0.81	1.31 %	$ 4.42 M	China
Adverum Biotechnologies ADVM	1.61 M	-	-	$ 86.2 M	USA
AgeX Therapeutics AGE	1.41 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	677 K	-	-	$ 1.01 B	USA
I-Mab IMAB	570 M	-	-	$ 866 M	China
Akero Therapeutics AKRO	9.03 M	-	-	$ 3.67 B	USA
Albireo Pharma ALBO	6.52 M	-	-0.23 %	$ 916 M	USA
Allena Pharmaceuticals ALNA	1.03 M	-	3.16 %	$ 1.9 M	USA
AlloVir ALVR	247 K	-	4.14 %	$ 49.1 M	USA
Akouos AKUS	1.28 M	-	0.23 %	$ 488 M	USA
Ampio Pharmaceuticals AMPE	750 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	1.58 M	-	-	$ 10.1 M	USA
Acorda Therapeutics ACOR	13.4 M	-	-24.86 %	$ 820 K	USA
Acer Therapeutics ACER	3.81 M	-	2.71 %	$ 14 M	USA
Aravive ARAV	8.76 M	-	-13.39 %	$ 1.45 M	USA
Applied Genetic Technologies Corporation AGTC	2.91 M	-	-	$ 26.5 M	USA
Avenue Therapeutics ATXI	155 K	-	-52.27 %	$ 4.45 M	USA
Atea Pharmaceuticals AVIR	4.46 M	$ 4.66	1.42 %	$ 393 M	USA
Axsome Therapeutics AXSM	65.5 M	$ 167.61	-4.09 %	$ 8.34 B	USA
Ayala Pharmaceuticals AYLA	4.08 M	-	-	$ 7.46 M	Israel
Atreca BCEL	1.74 M	-	-11.76 %	$ 5.79 M	USA
Alpine Immune Sciences ALPN	4.29 M	-	-	$ 2.17 B	USA
BioDelivery Sciences International BDSI	8.11 M	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	405 M	-	0.49 %	$ 251 B	Cayman-islands
Biogen BIIB	432 M	$ 194.87	-0.75 %	$ 28.5 B	USA
BioVie BIVI	2.2 M	$ 1.25	0.4 %	$ 1.85 M	USA
Bellicum Pharmaceuticals BLCM	486 K	-	-9.72 %	$ 5.89 M	USA
BioMarin Pharmaceutical BMRN	32.8 M	$ 63.02	0.15 %	$ 12 B	USA
Baudax Bio BXRX	3.93 M	-	0.59 %	$ 63 K	USA
Aptose Biosciences APTO	1.26 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	724 K	-	-39.0 %	$ 4.57 M	USA
Aridis Pharmaceuticals ARDS	2.31 M	-	17.91 %	$ 11.1 M	USA
Amneal Pharmaceuticals AMRX	153 M	$ 14.72	2.08 %	$ 4.55 B	USA
Calithera Biosciences CALA	3.65 M	-	-10.95 %	$ 876 K	USA
Arena Pharmaceuticals ARNA	13.3 M	-	-6.81 %	$ 3.04 B	USA